Indegene Inaugurates New Center in Hyderabad to Empower Global Business
This move aligns with Indegene’s purpose to enable healthcare organizations to be future-ready by combining deep medical expertise with fit-for-purpose technology.
Global Pharma | 18/11/2024 | By Aishwarya
Effects of rilzabrutinib in individuals with insusceptible thrombocytopenia
Positive phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine
Global Pharma | 16/04/2022 | By Sudeep Soparkar | 575
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy